Skip to content
Four biotech companies will receive a total of $1.4 billion in grants for the purpose of developing new vaccines and other treatments, the U.S. […]
HHS grants $1.4 billion for new COVID-19 vaccines and treatments Read More »
The U.S. Food and Drug Administration (FDA) approved Pfizer’s respiratory syncytial virus vaccine, Abrysvo, to prevent RSV in infants. The August 21 decision comes
FDA approves first vaccine to prevent RSV in infants Read More »
Imagine if you are diagnosed with cancer and now your treatment is delayed because you are denied immediate access to the medications you need.
Rising denials by health insurance plans are harming the patients they ‘serve’ Read More »
COVID-19 vaccines can be a big help to cancer patients and others with immunocompromised conditions. During the initial rollout of the COVID-19 vaccine, under
5 ways COVID-19 vaccines benefit patients with cancer Read More »
The state legislatures have been as busy as ever in 2023—especially in the health care sector. Now, as many legislatures across the country are
What’s been happening in state legislatures on health care Read More »
As part of our coverage of the National Institute of Health’s (NIH) Innovation Zone at the 2023 Biotechnology Innovation Organization (BIO) International Convention in Boston,
NIH Innovation Zone: OculoTherapy’s unique therapeutics for glaucoma and eye disease Read More »
Respiratory syncytial virus, or RSV, innovations are big news this year—and for good reason. The biotech industry has finally cracked the code for treating
Codagenix Q&A: Diversifying vaccination options for patients Read More »
The mifepristone saga is entering its next chapter. On August 16, 2023, the U.S. Court of Appeals for the Fifth Court for the Northern
Appeals court rules to restrict access to mifepristone Read More »
The “wild poliovirus” is nearly eradicated, with the only two countries where the virus remains endemic reporting just a handful of cases in 2022.
Polio is (almost) a thing of the past – and we have vaccines to thank Read More »
Childhood vaccination rates get a lot of attention, but it’s equally important to work on adult vaccination rates, too. “Right now, as a number
National Immunization Awareness Month: A conversation with GSK on adult vaccine access Read More »
